Social Media Ideas for Cosette Pharmaceuticals

Cosette Pharmaceuticals names Adams as vice president, supply chain and sourcing

Cosette Pharmaceuticals Inc. said Sept. 10 that it has appointed Andrew Adams as vice president, supply chain and sourcing. In this role, he will lead Cosette’s end-to-end supply c...

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

PRNewswireMumbai (Maharashtra) [India], October 1: Piramal Pharma Solutions ('PPS'), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal...

<![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

Renova Pharmaceuticals launches its first three generic products

Renova Pharmaceuticals LLC, a Fairfield-based drug company focused on bringing high-quality and affordable generic medicines to patients, announced Sept. 11 the commercial launch o...

Mayne Settles US Patent Suit With Teva Over Generic Imvexxy

ASX-listed Mayne Pharma announced on Friday another settlement related to its oestradiol vaginal insert Imvexxy, with medicines maker Teva Pharmaceuticals USA Inc. agreeing not to...

DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health...

Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

<![CDATA[M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz...

Group Acquires Energon Labs

Strengthening Global Pharmaceutical Testing Capabilities and Expanding its Presence in India

Cotecna Group Acquires Energon Labs, Strengthening Global Pharmaceutical Testing Capabilities and Expanding its Presence...

<![CDATA[Viatris Acquires Pacira BioSciences for $1.65 Billion ]]>

Ascend Rx Launches in PH as PRIMA’s Official Specialty Compounding Partner

Ascend Rx, a physician-focused specialty compounding pharmacy, formally launched in the Philippines at the PRIMA ASEAN Congress on Longevity, Regenerative Medicine, and Human Optim...

Pharmacosmos Therapeutics

Pharmacosmos Therapeutics Anonymous (not verified) Fri, 10/16/2026 - 10:12 field_thread_url https://cafepharma.com/boards/threads/pharmacosmos-therapeutics...

Eton's Galzin TM And False Ad Suit Survives Dismissal Bid

Eton Pharmaceuticals can proceed with trademark infringement and false advertising claims accusing Extreme V of marketing a dietary supplement as a Wilson disease treatment, with a...

NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals

Innovative Delivery Technologies Aimed at Enhancing Bioavailability and Expanding Patient Access Beyond Traditional Injections

Cotecna Group Acquires Energon Labs, Strengthening Global Pharmaceutical Testing Capabilities and Expanding its Presence...

GENEVA, Switzerland and HYDERABAD, India, [October 16, 2026] – Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, today announced the acquisition…...

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

<![CDATA[Aptar and Aceso Therapeutics Enter Collaboration for Cystic Fibrosis Therapy ]]>

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

Laboratoires Pierre Fabre appoints Zombré CEO of U.S. Dermocosmetics operations in Secaucus

Laboratoires Pierre Fabre, the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical groups, announced Aug. 25 the appointment of Nicolas Zombré...

<![CDATA[Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreeme...

<![CDATA[The Next Chapter in Metabolic Drug Development]]>

Viatris’s pipeline strategy: Moving beyond generics to find new growth 

Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find new growth. The post Viatris’s pipeline strategy: Movi...

Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex P...